CSR Biotech, a Qiming Venture Partners' portfolio company, showcased its independently developed super-resolution microscopy systems at the 15th China Life Science Public Platform Management and Development Symposium. CSR Biotech highlighted its latest breakthroughs and practical applications in super-resolution imaging. Among the products on display, the HIS-SIM system impressed attendees with its exceptional performance and intelligent operation, delivering precise insights for biomedical research. The SIM-Supreme stood out for its dual-modal super-resolution capability, combining fluorescence and label-free imaging to address the challenges of complex, multi-channel dynamic cellular observation. Meanwhile, Cell Xpanse pushed the boundaries of cellular imaging with high-throughput and deep-sectioning capabilities, opening up broader application prospects and taking multi-modal fluorescence super-resolution imaging into a new dimension. #SuperResolution #Microscopy #BiomedicalResearch #Innovation #AdvancedImaging #CellImaging #TechnologyForScience #QimingPortfolio #QimingHealthcare
